Aida Pharmaceuticals, Inc.
AIDA · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.5% | 20.9% | 56.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 50.3% | 52.5% | 66% | 70.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 25.1% | 20.3% | 15.5% | 23.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 9.4% | 4.9% | 6% | 10.5% |
| EPS Diluted | 0.1 | 0.06 | 0.06 | 0.07 |
| % Growth | 66.7% | 0% | -14.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | – |
| Capital Expenditures | -$0 | -$0 | -$0 | – |
| Free Cash Flow | $0 | -$0 | $0 | – |